We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Prostatectomy Patient Outcomes Affected by Surgeon's Total Case Load

By HospiMedica International staff writers
Posted on 22 Feb 2010
A new study suggests that prostate cancer patients treated by more experienced urologic surgeons with higher volumes of surgery achieve improved results.

Researchers at the Memorial Sloan-Kettering Cancer Center (New York, NY, USA) analyzed data from the 2005 U.S. More...
Nationwide Inpatient Sample and a complete record of all hospital discharges in New York State (USA) to determine typical annual radical prostatectomy caseloads of surgeons in the United States. The results show that a surgeon needs to have completed a minimum of 250 prostatectomies to reach the "learning curve plateau,” at which point cancer cure is maximized and surgical complications minimized. After adjusting for tumor severity, a typical patient treated by a surgeon who has reached the learning curve plateau had a 10.9% risk of recurrence at 5 years, compared to 17.7% for those treated by a less experienced surgeon. Similarly, surgical complications were decreased by 20% in patients treated by the highest versus the lowest volume surgeons studied.

Furthermore, for the 75% of patients diagnosed with cancers still confined to the prostate gland, the most highly experienced surgeons--who had performed at least 1,500 prior surgeries--achieved recurrence rates of less than 1%, suggesting that recurrence is largely dependent on surgical technique. Despite these findings, the researchers found that approximately 25% of U.S. surgeons performed only a single radical prostatectomy procedure per year, while about 80% of the surgeons performed fewer than 10 procedures per year. In all, according to the study, only 1.8% of surgeons in the United States perform more than 50 prostatectomies per year, and most surgeons will never reach the key threshold of 250 radical prostatectomy cases during their surgical careers. The study was published in the December 2009 issue of the Journal of Urology.

"The current pattern of surgical treatment for prostate cancer leads to many patients being treated by surgeons with low annual caseloads, with likely poorer outcomes as a result,” concluded study authors Caroline Savage, B.A., and Andrew Vickers, Ph.D., of the department of epidemiology and biostatistics.

"Practice patterns in which the majority of prostate cancers patients undergoing surgery are treated by surgeons performing fewer than 10 procedures a year suggest that better results may be achievable for many of these men,” commented Kevin Slawin, M.D., director of urology at Memorial Hermann-Texas Medical Center (Houston, USA). "The study provided data that supports what common sense suggests - that a more experienced surgeon will likely produce more positive results for patients undergoing a procedure as technically complex and challenging as radical prostatectomy.”

Related Links:

Memorial Sloan-Kettering Cancer Center
Memorial Hermann-Texas Medical Center




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.